WCBA
LLY icon

Weaver C. Barksdale & Associates’s Eli Lilly LLY Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,427
Closed -$117K – 493
2017
Q2 		$117K Hold
1,427
– – 0.14% 68
2017
Q1 		$120K Sell
1,427
-110
-7% -$8.81K 0.14% 70
2016
Q4 		$113K Sell
1,537
-8,587
-85% -$639K 0.18% 64
2016
Q3 		$813K Buy
10,124
+272
+3% +$21.8K 1.37% 51
2016
Q2 		$776K Hold
9,852
– – 1.35% 46
2016
Q1 		$709K Sell
9,852
-34
-0.3% -$2.57K 0.53% 77
2015
Q4 		$833K Hold
9,886
– – 0.65% 53
2015
Q3 		$827K Sell
9,886
-2,300
-19% -$194K 0.67% 44
2015
Q2 		$1.02M Hold
12,186
– – 0.75% 31
2015
Q1 		$885K Hold
12,186
– – 0.67% 36
2014
Q4 		$841K Sell
12,186
-288
-2% -$19.4K 0.68% 44
2014
Q3 		$809K Sell
12,474
-1,551
-11% -$98.2K 0.67% 44
2014
Q2 		$872K Hold
14,025
– – 0.7% 35
2014
Q1 		$826K Buy
+14,025
New +$783K 0.69% 35

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Weaver C. Barksdale & Associates's LLY Position: Q3 2017 in Review

Weaver C. Barksdale & Associates sold out of Eli Lilly (LLY) in Q3 2017, closing a stake of 1,427 shares — an estimated $117K sold.

Weaver C. Barksdale & Associates first reported a position in LLY in Q1 2014 and held it in 14 quarters. The position peaked at $1.02M in Q2 2015. 1,228 funds tracked by Wall St. Rank hold LLY as of Q3 2017.

  • Weaver C. Barksdale & Associates reported no remaining Eli Lilly position as of Q3 2017 after selling out during the quarter.
  • Weaver C. Barksdale & Associates sold 1,427 Eli Lilly shares in Q3 2017, an estimated $117K.
  • Weaver C. Barksdale & Associates first reported a position in Eli Lilly in Q1 2014 and held it in 14 quarters.
  • Weaver C. Barksdale & Associates's Eli Lilly position peaked at $1.02M in Q2 2015.
  • 1,228 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q3 2017, filed 12 Oct 2017.